SEC Form 4 · accession 0001232524-19-000002
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel N Swisher Jr.
Officer — President and COO
Period of report
Jan 3, 2019
Accepted (ET)
Jan 7, 2019 · 7:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Jan 3, 2019 | F | 1,604 | $126.01 | D | 16,512 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- F2Includes 116 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2018.